HRPP IRB Fees for Industry Sponsored Clinical Trials

October 1, 2025

Michigan State University (MSU) Human Research Protection Program (HRPP) Institutional Review Board (IRB) fees are charged for industry sponsored clinical trials. Government funded research, internally funded research, and non-funded research are not subject to an MSU HRPP IRB fee.

All investigators submitting industry sponsored clinical trials are required to include a separate line item(s) in the study budget for HRPP IRB fee(s). For studies reviewed by a commercial (Independent) IRB, the MSU HRPP IRB fee is in addition to fees charged by the commercial (independent) IRB.

HRPP IRB fees have not been increased since 2006. After benchmarking with other institutions, MSU HRPP/IRB fees were raised effective September 1, 2025.

The new fees apply to industry sponsored clinical trial agreements executed after September 1, 2025.

The new fees are:

Fees for Submissions Reviewed by the MSU Biomedical and Health IRB
	New Study Submission	Continuing Review*	Modifications / Reportable Events
Full Board	$ 3,000	$ 1,500	$ 0
Expedited	$ 2,000	$ 750	$ 0
Exempt	$ 1,000	$ 0	$ 0

*Continuing review includes continuing review submissions for study closure

 

Fees for Submissions Reviewed by a Commercial (Independent) IRB
	One-Time Fee
All Study Types	$ 2,500

 

HRPP IRB fees for industry sponsored clinical trial agreements executed on or before September 1, 2025 have not changed.

For fee information, please visit: Appendix 14-26, Michigan State University (MSU) Human Research Protection Program (HRPP) Institutional Review Board (IRB) Fees Industry Sponsored Clinical Trial Agreements

Please contact Kristen Koritnik, HRPP Director, if you have any questions: burtkris@msu.edu